Primary Handling Editor: Ashley Castellanos-Jankiewicz, in collaboration with the Nature Metabolism team
Key benefits: Helps reduce food intake and emotional eating Promotes 10-15% average body weight loss Lowers blood sugar and supports cardiovascular health Administered weekly by injection Learn more about semaglutide and how it works Tirzepatide Tirzepatide is a next-generation medication that stimulates both GLP-1 and GIP receptors, delivering enhanced metabolic effects
You can read the full article at Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial Obesity is a major public health issue worldwide
As part of your Shapely membership, your weight loss provider and our team of specialized coordinators can send a prior authorization to your insurance to see if they will cover the medication for you
GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody
